Beware of tall stature: growth hormone excess associated with a rare parasellar extra-axial tumour—diagnostic and management challenges in a resource-limited setting
European Journal of Case Reports in Internal Medicine · 19.10.2026 · 13 (11)
DOI: 10.12890/2026_007424 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 19.10.2026. Verfasst von Marischa Tita Thiono und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Tall stature can be the sole indicator of growth hormone (GH) excess, which causes pituitary gigantism before epiphyseal fusion. In developing regions like Indonesia, a lack of systematic screening often delays diagnosis. While classic presentations involve accelerated linear growth, atypical cases may be dominated by neurological signs, such as seizures secondary to tumour mass effect. Case description: A 14-year-old boy presented with a 2-year history of rapidly accelerating growth velocity, increasing shoe size, and a 6-month history of severe morning headaches accompanied by drug-resistant focal seizures. Endocrine evaluations revealed significantly elevated basal GH (4.27 ng/ml) and insulin-like growth factor 1 (IGF-1) levels (536 ng/ml). Brain magnetic resonance imaging identified a large parasellar extra-axial tumour with suprasellar extension. The patient underwent a craniotomy and tumour excision; histopathology subsequently confirmed a rare, aggressive malignant mesenchymal tumour. Postoperatively, the patient achieved seizure resolution and normalization of GH and IGF-1 levels. However, he developed evolving pituitary dysfunction consistent with multiple pituitary hormone deficiency (MPHD), specifically central hypothyroidism, necessitating targeted hormonal replacement therapy and continuous clinical follow-up.
Conclusion
GH excess and gigantism can arise secondary to parasellar pathology rather than intrinsic pituitary disease, with neurological features like refractory epilepsy occasionally preceding classic endocrine manifestations. Rapid adolescent growth paired with neurological signs warrants urgent structural neuroimaging. Meticulous perioperative pituitary monitoring and early multidisciplinary involvement are essential to optimize long-term patient outcomes
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Child Health, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
- Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.
- Department of Child Health, Universitas Airlangga Hospital, Surabaya, Indonesia.
Zitieren
APA
Thiono, M. T., Perwitasari, R. K., Hisbiyah, Y., Noviandi, R., Faizi, M., & Rochmah, N. (2026). Beware of tall stature: growth hormone excess associated with a rare parasellar extra-axial tumour—diagnostic and management challenges in a resource-limited setting. European Journal of Case Reports in Internal Medicine, 13(11). https://doi.org/10.12890/2026_007424
Vancouver
Thiono MT, Perwitasari RK, Hisbiyah Y, Noviandi R, Faizi M, Rochmah N. Beware of tall stature: growth hormone excess associated with a rare parasellar extra-axial tumour—diagnostic and management challenges in a resource-limited setting. European Journal of Case Reports in Internal Medicine. 2026;13(11). doi:10.12890/2026_007424
BibTeX
@article{Thiono2026,
author = {Thiono, Marischa Tita and Perwitasari, Rayi Kurnia and Hisbiyah, Yuni and Noviandi, Riza and Faizi, Muhammad and Rochmah, Nur},
title = {Beware of tall stature: growth hormone excess associated with a rare parasellar extra-axial tumour—diagnostic and management challenges in a resource-limited setting},
journal = {European Journal of Case Reports in Internal Medicine},
year = {2026},
volume = {13},
number = {11},
doi = {10.12890/2026_007424}
}
EUVIMED